Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Therapeutic Use of Oral Sodium Phosphate (Z-521) in Primary Hypophosphatemic Rickets

NCT01237288 is registered in ClinicalTrials.gov with Zeria Pharmaceutical as lead sponsor.

NCT NCT01237288
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01237288 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Therapeutic Use of Oral Sodium Phosphate (Z-521) in Primary Hypophosphatemic Rickets
Lead sponsor
Zeria Pharmaceutical
Phase
Phase 3
Overall status
Completed
Start date
September 30, 2010
Completion date
July 31, 2013
Enrollment
16 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

primary hypophosphatemic rickets